We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis To Settle Sales Reps' OT Claims For $99M

Law360, New York (January 25, 2012, 12:36 PM EST) -- Novartis Pharmaceuticals Corp. has agreed to pay $99 million to resolve claims brought in New York federal court by a class of drug sales representatives who allege they were misclassified as...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.